Alimera Sciences
Stock Forecast, Prediction & Price Target
Alimera Sciences Financial Estimates
Alimera Sciences Revenue Estimates
Alimera Sciences EBITDA Estimates
Alimera Sciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $59.02M N/A | $54.12M -8.30% | $80.75M 49.18% | Avg: $121.03M Low: $118.47M High: $123.77M avg. 49.87% | Avg: $135.91M Low: $133.04M High: $138.98M avg. 12.29% | Avg: $191.49M Low: $187.44M High: $195.82M avg. 40.89% | Avg: $229.44M Low: $224.60M High: $234.64M avg. 19.82% |
Net Income
% change YoY
| $-4.37M N/A | $-18.10M -314.15% | $-20.13M -11.18% | Avg: $10.43M Low: $1.78M High: $7.41M avg. 151.83% | Avg: $23.93M Low: $5.87M High: $16.10M avg. 129.33% | Avg: $25.81M Low: $25.10M High: $26.57M avg. 7.88% | Avg: $39.87M Low: $38.78M High: $41.05M avg. 54.45% |
EBITDA
% change YoY
| $2.37M N/A | $-8.93M -475.69% | $7.27M 181.44% | Avg: $-984.63K Low: $-1.00M High: $-963.83K avg. -113.53% | Avg: $-1.10M Low: $-1.13M High: $-1.08M avg. -12.29% | Avg: $-1.55M Low: $-1.59M High: $-1.52M avg. -40.89% | Avg: $-1.86M Low: $-1.90M High: $-1.82M avg. -19.82% |
EPS
% change YoY
| -$0.66 N/A | -$2.59 -292.42% | -$0.79 69.49% | Avg: $0.19 Low: $0.07 High: $0.29 avg. 124.05% | Avg: $0.43 Low: $0.23 High: $0.63 avg. 126.31% | Avg: $1.01 Low: $0.98 High: $1.04 avg. 134.88% | Avg: $1.56 Low: $1.52 High: $1.61 avg. 54.45% |
Operating Expenses
% change YoY
| $52.2M N/A | $57.79M 10.71% | $62.64M 8.39% | Avg: $78.60M Low: $76.94M High: $80.39M avg. 25.49% | Avg: $88.27M Low: $86.40M High: $90.27M avg. 12.29% | Avg: $124.37M Low: $121.74M High: $127.18M avg. 40.89% | Avg: $149.02M Low: $145.87M High: $152.40M avg. 19.82% |
FAQ
What is Alimera Sciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 85.87% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is 1.78M, average is 10.43M and high is 7.41M.
What is Alimera Sciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 30.72% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $118.47M, average is $121.03M and high is $123.77M.
What is Alimera Sciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 109.92% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is $0.07, average is $0.19 and high is $0.29.
What is the best performing analyst?
In the last twelve months analysts have been covering Alimera Sciences stock. The most successful analyst is Yi Chen.